Latest News

Date Title Topic
10 Sep 2017 ESMO 2017 Press Release: Mature Results Favour Pembrolizumab As Second-line Treatment For Bladder Cancer Genitourinary cancers
10 Sep 2017 ESMO 2017 Press Release: Licensing and Reimbursement Discrepancies Impact Patient Access to Cancer Treatment
10 Sep 2017 ESMO 2017 Press Release: Abemaciclib Initial Therapy Improves Outcome in Endocrine-sensitive Advanced Breast Cancer Breast cancer
10 Sep 2017 ESMO 2017 Press Release: Ramucirumab plus Docetaxel Improves Progression-free survival in Urothelial Cancer Genitourinary cancers
10 Sep 2017 ESMO 2017 Press Release: Combination Immunotherapy in Second/third Line Extends Mesothelioma Survival to 15 Months Lung and other thoracic tumours
10 Sep 2017 ESMO 2017 Press Release: Abdominal Fat a Key Cancer Driver for Postmenopausal Women
10 Sep 2017 ESMO 2017 Press Release: Study Shows ESMO Magnitude of Benefit Scale Can Be Used to Grade Orphan Drugs
10 Sep 2017 ESMO 2017 Press Release: Study Confirms Chemoradiation is Best Treatment for Locally Advanced Cervical Cancer Gynaecologic malignancies
10 Sep 2017 ESMO 2017 Press Release: Cancer Patients Struggle with Key Aspects of Clinical Trial Methodology
09 Sep 2017 ESMO 2017: Front-Line Osimertinib Poised to Become Standard of Care in EGFR-Mutation Positive NSCLC Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
09 Sep 2017 ESMO 2017: Durvalumab as Consolidation Therapy Prolongs PFS in Stage III NSCLC Patients Without Progression Following Platinum-based Chemoradiotherapy Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
09 Sep 2017 ESMO 2017: Tumour Subtype Specific Genetic Alterations Detected by Comprehensive Genomic Profiling Translational research
09 Sep 2017 ESMO 2017: Overall Survival Benefit is Seen with Olaparib in Patients with Ovarian Cancer and TP53 Disruptive Mutation Status Gynaecologic malignancies - Anticancer agents & Biologic therapy
09 Sep 2017 ESMO 2017: Webcasts
09 Sep 2017 ESMO 2017: Daily Broadcasts